LOS ANGELES CAPITAL MANAGEMENT LLC - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 149 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.

Quarter-by-quarter ownership
LOS ANGELES CAPITAL MANAGEMENT LLC ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q2 2023$303,205
+2.7%
10,572
-14.2%
0.00%0.0%
Q1 2023$295,358
+41.3%
12,3220.0%0.00%0.0%
Q4 2022$208,981
+14.2%
12,3220.0%0.00%0.0%
Q3 2022$183,000
-5.7%
12,3220.0%0.00%0.0%
Q2 2022$194,000
-87.9%
12,322
-79.3%
0.00%
-83.3%
Q1 2022$1,608,000
+468.2%
59,630
+613.5%
0.01%
+500.0%
Q2 2021$283,0008,3570.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q3 2023
NameSharesValueWeighting ↓
Tri Locum Partners LP 208,886$5,337,0371.71%
Portolan Capital Management 276,505$7,064,7030.66%
Nikko Asset Management Americas, Inc. 1,388,574$35,422,5230.42%
Green Alpha Advisors, LLC 21,538$550,2960.42%
SummerHaven Investment Management, LLC 22,326$570,4290.42%
ARK Investment Management 1,901,546$48,584,5080.37%
Granahan Investment Management 398,862$10,190,9240.36%
FEDERATED HERMES, INC. 4,711,512$120,379,1320.32%
Woodline Partners LP 1,069,814$27,333,7480.32%
Diametric Capital, LP 26,130$667,6210.28%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders